|
⚲
|
| HEP Management Corporation
✚
| |
|---|---|
| CRD # | 161855 |
| SEC # | 801-78087 |
| CIK # | 0001618035 |
| AUM | $420.5 MM (2024-03-14) |
| Employees | 7 (86% Investors, 0% Brokers) |
| Phone | 212-981-6901 |
| Address | 565 Fifth Avenue New York, NY 10017-2470 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($MM) |
|---|
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| PE | Health Enterprise Partners IV LP | [2022-03-25] | 0.0 | 202.3 |
| PE | Health Enterprise Partners III LP | [2018-03-28] | 177.5 | 155.9 |
| PE | Health Enterprise Partners II LP | [2012-10-09] | 136.4 | 59.2 |
| PE | Health Enterprise Partners LP | 2012-02-27 | 5.7 |
| AUM Breakdown | Accounts | AUM ($MM) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 420.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 420.5 |
| By Discretionary | ||
| Discretionary | 4 | 420.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 420.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 420.5 | |
| Total | 4 | 420.5 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 |
|---|---|---|---|
| Robert Schulz | 14 | ||
| Daniel Cain | 5 | ||
| David Tamburri | 38 | ||
| Richard Stowe | 11 | ||
| Ezra Mehlman | 9 | ||
| Peter Tedesco | 3 | ||
| HEP Associates IV LLC | 1 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 3 | [0001618035] | |
| 4 | [0001618035] | |
| SC 13D | [0001618035] | |
| SC 13G | [0001618035] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| HEP Investments LLC | ZIVO Bioscience Inc | [2018-04-25] |
| HEP Investments LLC | ZIVO Bioscience Inc | [2015-05-01] |
| HEP Investments LLC | Health Enhancement Products Inc | [2014-09-04] |
| Form 3/4/5 Subject | 2011 - 2024 |
|---|---|
| HEP Investments LLC | |
| Zivo Bioscience, Inc. |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Hammond Kennedy Whitney & Company Inc
✚
|
IN | 0.6 |
|
UMB Asset Management LLC
✚
|
MO | 0.1 |
|
Thoma Cressey Bravo Inc
✚
|
IL | 0.0 |
|
Blackstreet Capital Advisors II LLC
✚
|
MD | 0.0 |
|
AG Dillon Asset Management LP
✚
|
NY | 0.0 |
|
Hillcap Partners LLC
✚
|
TX | 0.0 |
|
Summation Capital Management LP
✚
|
NY | 0.0 |
|
Guochuang Securities Limited
✚
|
CO | 0.0 |
|
TJSS LLC
✚
|
NY | 0.0 |
|
Morgan Stanley Smith Barney Private Management LLC
✚
|
NY | 0.0 |